A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects
Clinical trial NCT01858935 · COMPLETED
Trial details
- NCT number
- NCT01858935
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-02-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.